Matted Lymph Nodes ID Poor Oropharyngeal SCC Prognosis

This article originally appeared here.
Share this content:
Matted Lymph Nodes ID Poor Oropharyngeal SCC Prognosis
Matted Lymph Nodes ID Poor Oropharyngeal SCC Prognosis

(HealthDay News) – Patients with oropharyngeal squamous cell carcinoma (SCC) who present with matted nodes have a worse prognosis than those without matted nodes, according to a study published online January 13 in Head & Neck.

Matthew E. Spector, MD, of the University of Michigan Health System in Ann Arbor, and colleagues investigated the correlation between patterns of local-regional tumor extent and distant metastasis in 78 untreated patients with oropharyngeal SCC, who were participating in a concurrent chemoradiation protocol. Human papillomavirus (HPV) in situ hybridization and epidermal growth factor receptor immunointensity were assessed. Of the 78 patients, 16 had matted lymph nodes.

The researchers found that the three-year disease-specific survival was 94% for patients without matted lymph nodes versus 69% for patients with matted lymph nodes (P=0.003). The lower survival associated with matted nodes was independent of known prognostic factors, including T classification, HPV status, epidermal growth factor receptor status, and smoking status. Seven of the eleven patients who were HPV positive died of distant metastases, and matted nodes were seen in six of the seven with distant metastases.

"Matted nodes are a novel marker of poor prognosis in oropharyngeal SCC, independent of established prognostic factors. Matted nodes may identify patients at risk for the development of distant metastasis who could benefit from systemic therapy," the authors write.

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs